Beyond Air, Inc, a biopharmaceutical company and a medical device in the commercial phase, focused on the exploitation of nitrogen oxide (NO) to improve the life of patients, the expansion of his global sales channels for his “Lungfit -PH” system with several new sales agreements, the four countries. Including France, Romania, Türkiye and Morocco.
“The interest of the world in our Lungfit PH system, which just received CE markings about 15 weeks ago, is very strong. When it comes to the addition of these latest agreements, our international commercial imprint currently includes 18 countries, and we quickly go to the signing of additional agreements that will further expand our sales network,” said Steve Lisi, Chairman of the Council and CEO of Beyond Air in one statement.
The company listed in Nasdaq will have as a partner in Morocco, Oxyplus. Note that the “Lungfit -PH” of Beyond Air nitrogen oxide generates the ambient air and thus eliminates the need for conventional high -pressure bottles. This reservoir technology rationalizes the company, improves efficiency and supports sustainability efforts in a hospital environment.
